EDITORIAL
Published on 21 Apr 2020
Editorial: IBD Management—Novel Targets and Therapeutic Perspectives
doi 10.3389/fphar.2020.00448
- 2,349 views
- 3 citations
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- IBD Management - Novel Targets and Therapeutic Perspectives
IBD Management - Novel Targets and Therapeutic Perspectives
31k
Total downloads
199k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 18 Jun 2019
Novel Pharmacological Therapy in Inflammatory Bowel Diseases: Beyond Anti-Tumor Necrosis Factor
doi 10.3389/fphar.2019.00671
- 7,911 views
- 64 citations
REVIEW
Published on 24 Apr 2019
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
doi 10.3389/fphar.2019.00314
- 6,678 views
- 28 citations
MINI REVIEW
Published on 29 Mar 2019
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
doi 10.3389/fphar.2019.00305
- 102,640 views
- 96 citations
SYSTEMATIC REVIEW
Published on 19 Mar 2019
Is There a Risk of Lymphoma Associated With Anti-tumor Necrosis Factor Drugs in Patients With Inflammatory Bowel Disease? A Systematic Review of Observational Studies
doi 10.3389/fphar.2019.00247
- 9,090 views
- 16 citations
REVIEW
Published on 13 Mar 2019
Targeting Cytokine Signaling and Lymphocyte Traffic via Small Molecules in Inflammatory Bowel Disease: JAK Inhibitors and S1PR Agonists
doi 10.3389/fphar.2019.00212
- 18,427 views
- 106 citations
MINI REVIEW
Published on 08 Feb 2019
Hsp60 as a Novel Target in IBD Management: A Prospect
doi 10.3389/fphar.2019.00026
- 5,168 views
- 27 citations
ORIGINAL RESEARCH
Published on 01 Feb 2019
Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease
doi 10.3389/fphar.2019.00039
- 7,586 views
- 32 citations
REVIEW
Published on 10 Jan 2019
Microbial-Based Therapies in the Treatment of Inflammatory Bowel Disease – An Overview of Human Studies
doi 10.3389/fphar.2018.01571
- 14,987 views
- 104 citations
ORIGINAL RESEARCH
Published on 03 Dec 2018
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation
doi 10.3389/fphar.2018.01405
- 3,998 views
- 39 citations
ORIGINAL RESEARCH
Published on 31 Oct 2018
Qingchang Suppository Ameliorates Colonic Vascular Permeability in Dextran-Sulfate-Sodium-Induced Colitis
doi 10.3389/fphar.2018.01235
- 4,096 views
- 28 citations
REVIEW
Published on 08 Oct 2018
Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring
doi 10.3389/fphar.2018.01107
- 11,175 views
- 49 citations
Published in
Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Inflammation Pharmacology
Participating Journals
Frontiers in Immunology
Inflammation PharmacologyOffline
- 5.7 impact factor
- 9.8 citescore
Impact
- 199kTopic views
- 165kArticle views
- 31kArticle downloads